ECSP066507A - Moduladores de la p-selectina glicoproteina ligando psgl- i - Google Patents

Moduladores de la p-selectina glicoproteina ligando psgl- i

Info

Publication number
ECSP066507A
ECSP066507A EC2006006507A ECSP066507A ECSP066507A EC SP066507 A ECSP066507 A EC SP066507A EC 2006006507 A EC2006006507 A EC 2006006507A EC SP066507 A ECSP066507 A EC SP066507A EC SP066507 A ECSP066507 A EC SP066507A
Authority
EC
Ecuador
Prior art keywords
cell
glicoprotein
selectine
modulators
cells
Prior art date
Application number
EC2006006507A
Other languages
English (en)
Inventor
Rong-Hwa Lin
Chung Nan Chang
Original Assignee
Abgenomics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/662,906 external-priority patent/US20040116333A1/en
Application filed by Abgenomics Corp filed Critical Abgenomics Corp
Publication of ECSP066507A publication Critical patent/ECSP066507A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Los compuestos multiméricos que se uno a P-Selectina Glicoproteina 1 (PSGL-1) sobre la superficie de las células T or natural killer (NK) cells pueden ser usadas para inducir a la célula T o la agotamiento de la céula NK y/o para inducir a la célula T o la apoptosis de la célula NK. Los compuestos multiméricos y métodos de la invención pueden ser usados para controlar las células T no deseadas o las inmuno respuestas mediadas por la célula NK en condiciones, tales como enfermedades inflamatorias, enfermedades autoinmunes, rechazo de transplantes y enfermedades alérgicas.
EC2006006507A 2003-09-15 2006-04-13 Moduladores de la p-selectina glicoproteina ligando psgl- i ECSP066507A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/662,906 US20040116333A1 (en) 2001-08-03 2003-09-15 Modulators of P-selectin glycoprotein ligand 1

Publications (1)

Publication Number Publication Date
ECSP066507A true ECSP066507A (es) 2006-10-10

Family

ID=36242362

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006507A ECSP066507A (es) 2003-09-15 2006-04-13 Moduladores de la p-selectina glicoproteina ligando psgl- i

Country Status (16)

Country Link
EP (1) EP1663290A4 (es)
JP (1) JP5808879B2 (es)
KR (1) KR101159140B1 (es)
CN (1) CN1852730B (es)
AU (1) AU2004273807B2 (es)
BR (1) BRPI0414402A (es)
CA (1) CA2538284C (es)
EC (1) ECSP066507A (es)
IL (1) IL174172A (es)
NO (1) NO20061306L (es)
NZ (1) NZ546203A (es)
RU (1) RU2407539C2 (es)
SG (1) SG146670A1 (es)
TW (2) TWI359024B (es)
UA (1) UA91004C2 (es)
ZA (1) ZA200602151B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2565872C (en) * 2004-05-11 2016-06-21 Abgenomics Corporation T-cell death-inducing epitopes
WO2009139459A1 (ja) * 2008-05-15 2009-11-19 国立大学法人 岡山大学 Ｐｓｇｌ－１阻害によるメタボリックシンドロームの予防及び治療法
TWI753875B (zh) * 2016-01-08 2022-02-01 美商美國全心醫藥生技股份有限公司 四價抗psgl-1抗體及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843707A (en) 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
US6117977A (en) * 1996-04-24 2000-09-12 Genentech, Inc. Type C lectins
ZA973051B (en) * 1996-04-24 1998-10-12 Genentech Inc Type c lectins
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

Also Published As

Publication number Publication date
CN1852730A (zh) 2006-10-25
AU2004273807A1 (en) 2005-03-31
IL174172A (en) 2011-12-29
CA2538284A1 (en) 2005-03-31
AU2004273807B2 (en) 2011-06-09
TW201012472A (en) 2010-04-01
KR101159140B1 (ko) 2012-06-22
NO20061306L (no) 2006-06-14
JP2007533618A (ja) 2007-11-22
IL174172A0 (en) 2006-08-01
RU2006112399A (ru) 2006-08-10
CN1852730B (zh) 2012-05-30
CA2538284C (en) 2015-10-20
SG146670A1 (en) 2008-10-30
TWI359024B (en) 2012-03-01
UA91004C2 (uk) 2010-06-25
JP5808879B2 (ja) 2015-11-10
RU2407539C2 (ru) 2010-12-27
KR20060088104A (ko) 2006-08-03
NZ546203A (en) 2009-05-31
TW200513262A (en) 2005-04-16
BRPI0414402A (pt) 2006-11-14
EP1663290A4 (en) 2009-07-01
EP1663290A2 (en) 2006-06-07
ZA200602151B (en) 2013-08-28

Similar Documents

Publication Publication Date Title
CY1108701T1 (el) Ρυθμιστες του γλυκοπρωτεϊνικου προσδεματος 1 της ρ-σελεκτινης.
CY1119097T1 (el) Σιωπηλες παραλλαγες fc των anti-cd40 αντισωματων
BR112019005633A8 (pt) Tcrs específicos para antigênio ha-1 de histocompatibilidade (h) menor e usos dos mesmos
CO15279455A2 (es) Proceso de produccion de biomasa y metabolitos de microorganismos de la especie bacillus sp. y sus composiciones para el control biologico de plagas
AR120563A1 (es) Receptores de antígeno quimérico cd19 y cd22 y sus usos
CL2018000353A1 (es) Agentes inductores de la apoptosis para tratar el cáncer y enfermedades inmunes y autoinmunes
CU20110096A7 (es) Compuestos que expanden las células madre hematopoyéticas
PE20110020A1 (es) Inmunomodulacion mediante el uso de celulas madres de la placenta
PE20152005A1 (es) Dominios gla como agentes terapeuticos
ECSP11009946A (es) Anticuerpos Anti-CD37
IN2014DN09392A (es)
CL2008001620A1 (es) Induccion de fenotipo tolerogenico en celulas dendriticas maduras
GT201400066A (es) Agentes inductores de la apoptosis que pueden usarse para tratar el cáncer y las enfermedades inmunes y autoinmunes
AR082502A1 (es) Proteinas osteogenicas de diseño
GT200000200A (es) Compuestos de 2,4-diamino-pirimidina utiles como supresores de inmunidad.
CL2017001903A1 (es) Composición novedosa para uso en el incremento de eficacia de injerto de células madre hematopoyéticas después del trasplante
ECSP067055A (es) Epitopos inductores de muerte de celulas-t
AR047759A1 (es) Derivados de fenil - piperazina como moduladores de receptores muscarnicos
ECSP066507A (es) Moduladores de la p-selectina glicoproteina ligando psgl- i
AR117566A1 (es) Anticuerpos anti-trem-1 y sus usos
WO2005027831A3 (en) Modulators of p-selectin glycoprotein ligand 1
WO2006102209A3 (en) Cd34(+) cells and their methods of use
UY31847A (es) Nuevos derivados de imidazopiridinas, composiciones conteniéndolos y aplicaciones
MX2023010240A (es) Compuestos para activar células t asesinas naturales invariantes y métodos de uso en la eliminación de células senescentes inflamatorias.
EA201991408A1 (ru) Композиции и способы для элиминации cd137+ клеток